BioLinker is a Brazilian synthetic-biology startup founded in 2018 by University of Sao Paulo scientists and headquartered in Cotia, in Greater Sao Paulo. It uses cell-free protein synthesis and synthetic DNA technology to discover, develop and manufacture recombinant proteins, applying AI across its bioengineering workflows. The company already generates recurring revenue and funds its commercial development from its own operations.
1
Round
1
Industry
4
Tags
Oct 6, 2026
Latest raise
Funding activity · 1 round
Oct 6, 2026
$1.4M
Seed
Led by Axcell
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
